Search Results 2041-2050 of 19673 for hemoglobin

1. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   Hemoglobin (Hgb) >= 8 unless marrow was involved by CLL or RT, then Hgb >= 7 without transfusion =< 1 week prior to study registration (=< 14 days prior to ...

2. Phase 1 Study of Oral TP-1454 - Clinical Trials

   Hemoglobin ≥ 8 g/dL 10. Have acceptable coagulation status: 1. Patient has International Normalized Ratio (INR) or Prothrombin time (PT) ≤ 1.5 × ULN ...

3. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   Adequate hematological function defined by absolute neutrophil count (ANC) ≥ 1.5 × 10^9/L, platelet count ≥ 100 × 109/L, and hemoglobin ≥ 9 g/dL; ...

4. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   Hemoglobin level ≤ 80 g/L (8.0 g/dL). Platelet count ≤ 100 × 10^9/L (100,000 cells/mm3) or ≥ 1000 × 10^9/L (1,000,000 cells/mm3).*; White blood cell count ...

5. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

   ... hemoglobin by pulmonary function test (PFT) (within 7 days prior to enrollment). If unable to obtain PFTs, the criterion is: a pulse oximetry reading of ...

6. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

   - Hemoglobin >= 8.5 g/dL (may be transfused to reach criteria) (obtained =< 14 days prior to registration) - Total bilirubin < 2 x upper limit of normal ...

7. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

8. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

   ... hemoglobin value < 11 g/dL (males) or <10 g/dL (females); Triglycerides > 500 mg/dL (5.7 mmol/L); if participant is on lipid-lowering therapy, must be on ...

9. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Patients may be transfused or receive erythropoietic treatment to meet this criterion. AST, ALT, and alkaline phosphatase ≤ 2.5 x ...

10. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL. Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); ≤ 3.0 x ULN for patients with Gilbert's syndrome. Aspartate ...